Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2025

Tan PH, Ellis IO, Allison KH, Badve SS, Brogi E, Callagy G, et al. Malignant phyllodes tumours of the breast: the case for revising WHO's 'full house' diagnostic criteria. Histopathology. 2025.

Britto LS, Balasubramani D, Desai S, Phillips P, Trehan N, Cesarman E, et al. T Cells Spatially Regulate B Cell Receptor Signaling in Lymphomas through H3K9me3 Modifications. Adv Healthc Mater. 2025;14(5):e2401192.

2024

Bidot S, Yin J, Zhou P, Zhang L, Deeb KK, Smith G, et al. Genetic Profiling of African American Patients With Prostatic Adenocarcinoma Metastatic to the Lymph Nodes: A Pilot Study. Arch Pathol Lab Med. 2024;148(3):310-317.

Hissong E, Arora K, Andy C, Jessurun J, Yantiss RK. Histologic Manifestations of Gastrointestinal Adenovirus Infection After Stem Cell Transplant. Am J Surg Pathol. 2024.

Li Z, Zeng X, Shi B, Han J, Wu Z, Chen X, et al. Schnurri-3 controls osteogenic fate of Adipoq-lineage progenitors in bone marrow. J Orthop Translat. 2024;45:168-177.

Saunders KE, Gerken N, Khani F, Williamson SR, Wobker SE. Current gross examination and reporting patterns of post-neoadjuvant chemotherapy cystectomy specimens: Is it time for a standardized approach? Am J Clin Pathol. 2024.

Torres HM, Marino J, Simon MS, Singh HK, Westblade LF, Calfee DP. High touch surface bioburden associated with the use of disinfectants with and without continuously active disinfection in ambulatory care settings. Infect Control Hosp Epidemiol. 2024:1-3.

Papachristodoulou A, Heidegger I, Virk RK, Di Bernardo M, Kim JY, Laplaca C, et al. Metformin Overcomes the Consequences of NKX3.1 Loss to Suppress Prostate Cancer Progression. Eur Urol. 2024;85(4):361-372.

Patel SS. NPM1-Mutated Acute Myeloid Leukemia: Recent Developments and Open Questions. Pathobiology. 2024;91(1):18-29.

Soderquist CR, Freeman C, Lin W-, Leeman-Neill RJ, Gu Y, Carter MC, et al. Clinical Utility and Reimbursement of Next-Generation Sequencing-Based Testing for Myeloid Malignancies. J Mol Diagn. 2024;26(1):5-16.